WASHINGTON – The U.S. Environmental Protection Agency on Friday proposed new testing methods that will eventually measure the toxicity of five additional kinds of per- and polyfluoroalkyl substances, known collectively as PFAS. They are often called "forever chemicals" because they remain in the body for years.
Earlier incarnations of PFAS have been linked to cancer, high cholesterol, immune deficiencies, liver problems and reproductive issues. Two specific substances, PFOA and PFOS, are at the center of a national water pollution scandal that has led to contamination of water systems and private wells across the country.
In 2018, Maplewood-based 3M, a major producer of PFAS, settled a pollution suit with the Minnesota attorney general's office for $850 million.
The company still faces PFAS pollution suits in multiple states and localities, as well as class action personal injury suits and shareholder suits all charging that the company knew of health risks of PFOA and PFOS for decades before finally discontinuing their use in 2002.
Now, the company could face more questions about its use of the five PFAS as the EPA will test for links to "both cancer and noncancer effects, including potential effects on the endocrine, hepatic, urinary, immune, developmental, and reproductive systems."
At this point, EPA is seeking public comments on its proposed evaluation methods for the five commercial versions of PFAS. The five include perfluorodecanoic acid (PFDA), perfluorononanoic acid (PFNA), perfluorohexanoic acid (PFHxA), perfluorohexanesulfonate (PFHxS), and perfluorobutanoic acid (PFBA).
"PFBA is the only compound that currently has commercial relevance for 3M," a company spokeswoman told the Star Tribune.
She added that "3M supports appropriate science-based regulation of PFAS and believes a consistent and unified federal policy based on sound science can help avoid the cost and confusion of a state-by-state patchwork of regulations. We are pleased to see the U.S. EPA take the next step in this process."